Table 3.

Summarizing efficacy results of the 2 regimens.

	FLOX arm	3-week arm	P value
Partial responses	3 (12.5%)	2 (16%)	.23
Stable disease	5 (21%)	5 (21%)	.5
Clinical benefit	3/8 (37.5%)	4/8 (50%)	.19